David Roman's Stock Ratings

Goldman Sachs Analyst

David Roman is an analyst at Goldman Sachs. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/29/2025

Overall Average Return

-6.69%

Smart Score

37.8%

Overall Average Return Percentile

25th

Number of Ratings

34
Buy NowGet Alert
03/27/2025HQYBuy Now
HealthEquity
$86.968.1%
David Roman37%
$107 → $94MaintainsNeutralGet Alert
03/11/2025GEHCBuy Now
GE HealthCare Techs
$80.0124.98%
David Roman37%
$85 → $100UpgradeNeutral → BuyGet Alert
03/04/2025ABTBuy Now
Abbott Laboratories
$131.9716.69%
David Roman37%
$138 → $154MaintainsBuyGet Alert
03/03/2025TDOCBuy Now
Teladoc Health
$8.0960.69%
David Roman37%
$16 → $13MaintainsBuyGet Alert
03/03/2025TNDMBuy Now
Tandem Diabetes Care
$19.2824.48%
David Roman37%
$42 → $24MaintainsNeutralGet Alert
03/03/2025SOLVBuy Now
Solventum
$74.75-5.02%
David Roman37%
$63 → $71MaintainsSellGet Alert
03/03/2025LIVNBuy Now
LivaNova
$39.1340.56%
David Roman37%
$64 → $55MaintainsBuyGet Alert
02/26/2025BAXBuy Now
Baxter Intl
$33.7524.44%
David Roman37%
→ $42Reinstates → BuyGet Alert
02/24/2025IRTCBuy Now
iRhythm Technologies
$105.0018.1%
David Roman37%
$91 → $124MaintainsNeutralGet Alert
02/18/2025TDOCBuy Now
Teladoc Health
$8.0997.78%
David Roman37%
$14 → $16MaintainsBuyGet Alert
02/10/2025DOCSBuy Now
Doximity
$58.0937.72%
David Roman37%
$58 → $80MaintainsNeutralGet Alert
01/30/2025SYKBuy Now
Stryker
$364.5017.15%
David Roman37%
$384 → $427MaintainsNeutralGet Alert
12/05/2024EWBuy Now
Edwards Lifesciences
$70.9426.87%
David Roman37%
$81 → $90MaintainsBuyGet Alert
11/15/2024HQYBuy Now
HealthEquity
$86.9624.2%
David Roman37%
→ $108Initiates → NeutralGet Alert
11/15/2024TDOCBuy Now
Teladoc Health
$8.0973.05%
David Roman37%
→ $14Initiates → BuyGet Alert
11/15/2024DOCSBuy Now
Doximity
$58.09-0.15%
David Roman37%
→ $58Initiates → NeutralGet Alert
10/04/2024LIVNBuy Now
LivaNova
$39.1366.11%
David Roman37%
→ $65Initiates → BuyGet Alert
10/04/2024IRTCBuy Now
iRhythm Technologies
$105.00-25.71%
David Roman37%
→ $78Initiates → NeutralGet Alert
10/04/2024TNDMBuy Now
Tandem Diabetes Care
$19.28138.59%
David Roman37%
→ $46Initiates → NeutralGet Alert
08/12/2024SOLVBuy Now
Solventum
$74.75-27.76%
David Roman37%
$48 → $54MaintainsSellGet Alert
08/08/2024BAXBuy Now
Baxter Intl
$33.7518.52%
David Roman37%
$36 → $40MaintainsNeutralGet Alert
07/26/2024EWBuy Now
Edwards Lifesciences
$70.9428.28%
David Roman37%
$107 → $91MaintainsBuyGet Alert
07/10/2024SOLVBuy Now
Solventum
$74.75-35.79%
David Roman37%
$54 → $48MaintainsSellGet Alert
05/30/2024BSXBuy Now
Boston Scientific
$99.36-9.42%
David Roman37%
→ $90Initiates → BuyGet Alert
05/30/2024EWBuy Now
Edwards Lifesciences
$70.9450.83%
David Roman37%
→ $107Initiates → BuyGet Alert
05/30/2024SYKBuy Now
Stryker
$364.502.06%
David Roman37%
→ $372Initiates → NeutralGet Alert
05/30/2024ISRGBuy Now
Intuitive Surgical
$490.002.04%
David Roman37%
→ $500Initiates → BuyGet Alert
05/30/2024ABTBuy Now
Abbott Laboratories
$131.97-8.31%
David Roman37%
→ $121Initiates → BuyGet Alert
05/30/2024BDXBuy Now
Becton Dickinson
$227.5020.44%
David Roman37%
→ $274Initiates → BuyGet Alert
05/30/2024BAXBuy Now
Baxter Intl
$33.756.67%
David Roman37%
→ $36Initiates → NeutralGet Alert
05/30/2024SOLVBuy Now
Solventum
$74.75-27.76%
David Roman37%
→ $54Initiates → SellGet Alert
05/30/2024ZBHBuy Now
Zimmer Biomet Holdings
$112.2614.91%
David Roman37%
→ $129Initiates → NeutralGet Alert
05/30/2024MDTBuy Now
Medtronic
$87.47-5.11%
David Roman37%
→ $83Initiates → SellGet Alert
05/30/2024GEHCBuy Now
GE HealthCare Techs
$80.018.74%
David Roman37%
→ $87Initiates → NeutralGet Alert